According to the research reports of 23 Wall Street equities research analysts, the average twelve-month stock price forecast for Regeneron Pharmaceuticals is $1,097.05, with a high forecast of $1,300.00 and a low forecast of $720.00. Should I buy or sell Regeneron Pharmaceuticals stock right...
REGN Stock 12 Month Forecast All Analysts Top Analysts Average Price Target $1,165.37 ▲(1.78% Upside) eyJuYXZpZ2F0b3IiOnsiZGlzYWJsZWQiOnRydWV9LCJleHBvcnRpbmciOnsiZW5hYmxlZCI6ZmFsc2V9LCJ0aXRsZSI6eyJ0ZXh0IjpudWxsfSwiY2hhcnQiOnsiaGVpZ2h0IjoyMDAsInN0eWxlIjp7ImZvbnRGYW1pbHkiOiJSb2JvdG...
Regeneron Pharmaceuticals MarketRank™ Stock Analysis Analyst Rating Moderate Buy 2.68 Rating Score Upside/Downside 7.7% Upside $970.57 Price Target Short Interest Healthy 1.29% of Shares Sold Short Dividend Strength N/A Sustainability -2.69 ...
In February this year I forecast that Regeneron's (NASDAQ:NASDAQ:REGN) stock price could suffer in 2022, owing to the fact that its COVID antibody cocktail REGEN-COV was found to be ineffective against the Omicron strain of the virus, and its use correspondingly restricted by the FDA. REGEN...
thank you. this concludes the conference. thank you for your participation. you may now disconnect. read more current regn analysis and news view all earnings call transcripts like share comment recommended for you about regn stock symbol last price % chg 1d 5d 1m 6m 1y 5y 10y market ...
business operations. We are reaffirming our 2019 guidance for our effective tax rate to be in the range of 14% to 16%. I want to remind you that, as in prior years, we will have volatility from quarter-to-quarter in our tax rate due to the timing of deductions for stock-based ...
Regeneron is developing a Tranthyretin Amyloidosis ("ATTR") candidate with Intellia Therapeutics, which generated the first-ever clinical data supporting safety and efficacy of in vivo CRISPR genome editing in humans - sending Intellia's stock price soari...
About REGN Stock SymbolLast Price% Chg REGN 964.47 0.57% Post 951.63 -1.33% 1D 5D 1M 6M 1Y 5Y 10Y Mar'24Feb'24Jan '24Dec'23Nov'23Oct '236008001,000 Market Cap $103.64B PE (FWD) 21.56 Yield (TTM) - Rev Growth (YoY) 7.76% Prev. Close $959.04Compare to Pe...